Prostate Cancer becomes most commonly diagnosed cancer in England
pharmafile | January 28, 2020 | News story | Manufacturing and Production | Cancer, Cancer diagnoses, NHS England, breast cancer, prostate cancer
Prostate cancer has overtaken breast cancer to be the most commonly diagnosed cancer for the first time in England, latest figures show.
In 2018, there were nearly 8,000 more cases than in 2017. Overall there were 316,680 cancers diagnosed in 2018, with prostate being the most common type with 49,029 cases, with breast cancer close behind with 47,476 cases.
Public Health England says it is because more men are getting tested, thanks to increased awareness through things like the English football league carrying out awareness campaigns as well as celebrities like Stephen Fry opening up about his experience with the disease.
Lucy Elliss-Brookes, Head of Cancer Analysis at Public Health England, said: “Although we are seeing a continued rise in cancer diagnoses, it’s encouraging that we are also seeing increases in survival, as well as an overall decrease in emergency diagnoses of cancer.”
Catching cancer early is vital to stop it spreading to other parts of the body which increases the chance of death due to the disease.
Professor Peter Johnson, Professor at the University of Southampton, said these numbers are only going to increased and praised the heightened awareness from celebrities. He said “As people live longer, we’re likely to see prostate cancer diagnosed more often, and with well-known figures like Rod Stewart, Stephen Fry and Bill Turnbull all talking openly about their diagnosis, more people will be aware of the risk.”
Conor Kavanagh
Related Content
Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project
Bio-Sourcing and Zerion Pharma have announced that their collaboration to develop an oral form of …
Biocartis announces breast cancer research collaboration with US Mayo Clinic
Biocartis has announced a research collaboration with Mayo Clinic in the US, aiming to develop …
Blue Earth announces first UK patient received prostate cancer injection
Blue Earth Therapeutics, a clinical-stage company specialising in targeted radiotherapeutics, has announced that the first …
